Status:
COMPLETED
Pathophysiological Effects of Intrapleural Pressure Changes During Therapeutic Thoracentesis
Lead Sponsor:
Medical University of Warsaw
Collaborating Sponsors:
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences
Conditions:
Pleural Effusion
Exudative Pleuritis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Research project objectives. The project includes eight research hypotheses and eight corresponding study objectives. The most relevant objectives are: * Analysis of lung function and gas exchange p...
Eligibility Criteria
Inclusion
- age 18 - 85 years,
- pleural effusion occupying more than one third of the hemithorax on the posteroanterior chest radiograph,
- therapeutic thoracentesis planned on the basis of signs and symptoms as well as imaging and functional studies,
- no contraindications for thoracentesis,
- signed informed consent for participation in the study.
Exclusion
- poor performance status requiring maximal shortening of the procedure,
- instable hemodynamic or respiratory status unrelated to pleural effusion,
- respiratory failure requiring mechanical ventilation.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT02192138
Start Date
August 1 2014
End Date
January 1 2019
Last Update
November 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Warsaw
Warsaw, Poland, 02-097